Perimeter Medical names Adrian Mendes as CEO; appoints Dr. Josh Vose to board 

The board of Perimeter Medical Imaging AI (TSXV:PINK; OTC:PYNKF; FSE:4PC) appointed Adrian Mendes as CEO, effective immediately, succeeding Jeremy Sobotta, who has resigned for personal reasons, effective June 15, 2023.

Mr. Sobotta will work closely with Mr. Mendes over the coming weeks to ensure a smooth transition of responsibilities.

Mr. Mendes is an experienced technology executive with 25 years of experience building and scaling technology companies across many different industries. Most recently, he was the COO of Groq, an AI hardware company, which he joined shortly after its formation in 2016 and helped scale to one of the leading startups in that space.

In addition, Josh Vose, M.D., was appointed a director of Perimeter, effective immediately. Dr. Vose is an experienced medical device executive and corporate director with a longstanding history in scaling novel surgical technologies, particularly in breast oncology and reconstruction.

Most recently, Dr. Vose served as CEO and board member of SIA Health, where he led the company through its Series B financing, the commercial growth of DuraSorb, and acquisition by Integra LifeSciences (NASDAQ:IART).

“We are grateful for Jeremy’s many contributions and service to Perimeter, particularly his prudent management of the company’s finances as the business transitioned from development stage to commercial stage,” Suzanne Foster, chairwoman of Perimeter’s board, said in a statement.

Ms. Foster said Mr. Mendes is joining Perimeter at an “exciting time in the company’s growth as we focus on execution on commercial placements of the S-Series with continued advancement of the AI-enabled B-Series.”

In addition, she said Dr. Vose will be instrumental in providing guidance to the company’s ongoing clinical and regulatory strategy to accelerate the B-Series through clinical development and commercialization.

Mr. Mendes said the “hardworking team at Perimeter has done a wonderful job marrying OCT technology with world-class AI algorithms and developing products that will greatly help cancer surgery patients.”

Chamath Palihapitiya, CEO and founder of Social Capital and Perimeter’s largest shareholder, said “we’re excited to be bringing Adrian to the Perimeter team and believe he has the operational expertise necessary to rapidly move the company forward.”